Mechanisms and Factors Responsible for the Inhibition of Transposons During Fetal Gonad Development in Humans

Medical Termination of Pregnancy Clinical Trial

Official title:
Mechanisms and Factors Responsible for the Inhibition of Transposons During Fetal Gonad Development in Humans

Status Recruiting

Clinical Trial Summary

This is a single-centre study over 36 months for the inclusion of 30 patients. The selection and inclusion of patients will take place according to the criterion of Medical Termination of Pregnancy at 4 different gestational ages (8-12 weeks of gestation (WG)), 13-16 WG, 17-23 WG and 25-35 WG. The tissue analysed will principally be the gonads, other somatic tissue will also be systematically harvested in parallel (liver and psoas muscle) for control purposes. The gonads will be subjected to molecular biology analyses destined to quantify the expression of transposons and their inhibitors.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Medical Termination of Pregnancy
Voluntary Termination of Pregnancy

Clinical Trial Details

NCT number	NCT02171845
Study type	Observational
Source	Centre Hospitalier Universitaire Dijon
Contact	Patricia FAUQUE
Phone	3.80.29.50.31
Email	patricia.fauque@chu-dijon.fr
Status	Recruiting
Phase
Start date	January 29, 2014
Completion date	January 2027

View Details

See also
	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT06396338` - Voluntary Surgical Terminations of Pregnancy: Comparison of the Hemorrhagic Risk Depending on the Term
	Recruiting	`NCT06210308` - Preoperative Ultrasound Evaluation of Gastric Contents in Voluntary Termination of Pregnancy During the First Trimester
	Not yet recruiting	`NCT06140069` - Voluntary Termination of Pregnancy: Comparison of Women's Experiences Depending on the Method Used.